Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients

OBJECTIVE: To evaluate whether saxagliptin is non-inferior to basal-bolus insulin therapy for glycemic control in patients with controlled type 2 diabetes mellitus (T2DM) admitted to hospital with non-critical illnesses. RESEARCH DESIGN AND METHODS: This was an open-label, randomized controlled clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Rajesh, Schuman, Brooke, Hurwitz, Shelley, Metzger, Cheyenne, Bhandari, Shreya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372055/
https://www.ncbi.nlm.nih.gov/pubmed/28405346
http://dx.doi.org/10.1136/bmjdrc-2017-000394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372055/
https://www.ncbi.nlm.nih.gov/pubmed/28405346
http://dx.doi.org/10.1136/bmjdrc-2017-000394

Ejemplares similares